GSK Adopts Multifaceted Strategies For Chinese Drug Market
This article was originally published in PharmAsia News
GlaxoSmithKline is expanding its share of the Chinese drug market at double the rate of the industry average.
You may also be interested in...
Amgen exec calls for more informal agency feedback and alignment between review divisions in understanding design methodologies.
Keeping Track Of Thanksgiving Leftovers: Risdiplam, Artesunate Highlight Glut Of Submissions/Filings
Yes, we know they should be out of the fridge by now, but here are the highlights of submissions and filings during the Thanksgiving week.